Core Viewpoint - Analysts expect Idexx Laboratories (IDXX) to report quarterly earnings of $3.14 per share, reflecting a year-over-year increase of 12.1%, with revenues projected at $1.07 billion, up 9.7% from the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.5% in the last 30 days, indicating a reassessment of initial estimates by covering analysts [1][2]. Revenue Estimates - Revenue from the Companion Animal Group (CAG) is expected to reach $981.37 million, representing a 10% increase from the prior-year quarter [4]. - Revenue from Other segments is projected at $4.48 million, indicating a 1.8% increase year-over-year [4]. - Revenue from Livestock and Poultry Diagnostics (LPD) is estimated at $30.45 million, reflecting a 5% increase from the previous year [5]. - Water revenue is expected to be $54.46 million, showing an 8.6% increase year-over-year [5]. - Revenue from the Companion Animal Group in the United States is projected at $654.89 million, indicating an 8.4% year-over-year change [5]. - International revenue from the Companion Animal Group is estimated at $324.70 million, reflecting a 12.8% increase [6]. - LPD International revenue is expected to be $24.64 million, indicating a 5.1% increase [6]. - Water International revenue is projected at $26.02 million, reflecting a 10.7% increase [6]. Gross Profit Estimates - Gross Profit for the Companion Animal Group (CAG) is expected to reach 61.4%, up from 61.0% reported in the same quarter last year [7]. - Gross Profit for Other segments is projected at 26.2%, compared to 49.9% reported in the previous year [7]. - Gross Profit for LPD is expected to be 50.4%, slightly down from 50.5% reported last year [8]. - Gross Profit for Water is projected at 69.6%, up from 69.3% reported in the same quarter last year [8]. Market Performance - Shares of Idexx have experienced a -0.7% change in the past month, contrasting with a +3.8% move of the Zacks S&P 500 composite [8].